NEW YORK (Reuters Health) - Rates of malignant melanoma and skin cancer are increased before a diagnosis of Parkinson’s disease, new research suggests. This casts doubt on the notion that levodopa therapy for Parkinson’s disease may contribute to the observed higher risk of malignant melanoma in such patients.>>> Discuss This Story
